A Review Study on Punica granatum L. by Shaygannia, Erfaneh. et al.
Topical Review Article
A Review Study on Punica granatum L
Erfaneh Shaygannia1, Mahmoud Bahmani2,
Behnam Zamanzad1, and Mahmoud Rafieian-Kopaei1
Abstract
Punica granatum L (pomegranate) is a deciduous shrub, native to Iran. Nowadays, besides its use as a fruit, its medicinal properties
have attracted the interest of researchers of many countries. Pomegranate fruit has medicinal properties such as anti-
inflammatory and antibacterial activities. The pomegranate seed oil has inhibitory effect on skin and breast cancers. The
pomegranate seed oil has phytoestrogenic compounds and the fruit is rich in phenolic compounds with strong antioxidant activity.
Ellagic acid is one of the main components of pomegranate with phenolic structure and antioxidant activity. This review article
presents the recently published findings on different aspects of this plant focusing on its medicinal properties
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Introduction
Punica granatum L (pomegranate) is a deciduous shrub, native
to Iran. Pomegranate has extensively been used as a source of
traditional medicine.1,2 Pomegranate fruit has medicinal proper-
ties such as anti-inflammatory and antibacterial activities. The
pomegranate seed oil has inhibitory effect on skin and breast
cancers. The pomegranate seed oil has phytoestrogenic com-
pounds and the fruit is rich in phenolic compounds with strong
antioxidant activity. The fruit and bark of pomegranate are used
against intestinal parasites, dysentery, and diarrhea.1 The juice
and seeds are considered a tonic for throat and heart. It is used
to stop nose and gum bleeds and treating hemorrhoids.3
Today, Punica granatum L. as a fruit not only attracts a lot
of public interest but research is also focused on its medicinal
properties and food industry.3 So a wide range of research stud-
ies have already been launched in this field. However, there are
not enough studies performed on the medicinal properties of
pomegranate. This review article presents the recently pub-
lished findings on different aspects of this plant, with a focus
on its medicinal properties.
Geographical Origin and Distribution of
Pomegranate
Pomegranate (Punica granatum L.) is one of the first domesti-
cated fruits that has been cultivated from past times. It is indi-
genous to Iran and neighboring countries that gradually
developed in central Asia regions to Himalaya, Eyalet of Ana-
tolia, Middle East, and Mediterranean area. It also thrive in Ari-
zona and California, and has been cultivated in the
Mediterranean region, South Asia, and the Middle East
countries; Kandahar in Afghanistan is famous for its high-
quality pomegranate. Today, pomegranate is cultivated in most
regions of the world, including Iran, Spain, Italy, Afghanistan,
America, India, China, Russia, Uzbekistan, Morocco, and
Greece.4 Iran is one of the biggest producers of pomegranate
in the world. In Iran, Markazi, Yazd, Fars, Khorasan, and Ker-
man provinces have the highest production rates.1
Morphology and Echophysiology of
Pomegranate
Pomegranate is a shrub that reaches to 1.5 to 5 m in height, with
more or less irregular and thorny branches and glossy leaves that
appears as a deciduous shrub in temperate regions and as ever-
green in frigid regions. Punica granatum L belongs to the Puni-
caceae family and is the smallest plant family that includes 1
genus and 2 species, including the following: Punica granatum
(edible pomegranate) is indigenous to Iran and Mediterranean
regions, and Punica protopunica (inedible) is endogenous to
Socotra islands in Pacific Ocean. The other characteristics are:
Leaves: Leaves are seen as reciprocal in newly grown
branches and as integrated in spores.
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Flowers: 1-5 flowers, one of them terminal and the rest mar-
ginal, short or without peduncle, their color is red and
rarely yellow or white, odorless, and two-sex.
Fruit: Balausta in light red color to greenish yellow and
rarely in some species dark purple. It is 5 to 20 cm in dia-
meter and its weight varies from less than 200 g to more
than 800 g.
Seed: Seeds are produced in high amounts, are triangular,
albumin free, and embedded in aril.5
Pomegranate is one of the well-known fruits having long-
term history in Iran and Middle East. This plant is mostly easy
to grow in desert margins with hot dry summer and scorching
heat of the sun and rather cold winter having saline water and
soil. This wide compatibility range is considered as favorable
ecophysiological condition for Punica granatum L, and so it
is called Kavir ruby. Pomegranate grows in a wide range of cli-
matic condition and can adapt itself to different types of soils.
However, this plant is sensitive to soils that have low drainage
and its growth in this condition is low and product quality is
decreased. The best soil condition to cultivate pomegranate is
deep sandy clay soils and the most growth, performance and
quality of product is in regions with hot and long summers.
This product can be grown up to an altitude of about 1600 m
above sea level. Some species of this product are well grown
in low heights and some other in higher heights. One of the
most important limitations of cultivating pomegranate is its
sensitivity to coldness. Pomegranate is damaged in tempera-
tures lower than 12C and so sweet pomegranates are more sen-
sitive than sour ones. In this plant, temperature below 7C is
needed and fruit needs long and hot summers to ripen.4,5
The Metabolites of Punica granatum L
The metabolites in various parts of the Punica granatum L fruit
and tree include various kinds of sugars, organic acids, poly-
phenols, flavonoids, anthocyanins, fatty acids, alkaloids, vita-
mins, and so on. The main sugars included in Punica
granatum L extract are composed of glucose, fructose, sucrose,
and maltose, while the vitamins are C, B1, B2, and beta-
carotene. Additionally, malic acid, fumaric acid, oxalic acid,
succinic acid, citric acid, and tartaric acid are among the major
organic acids in Punica granatum L. Alkaloids found in pome-
granate peel include ellagic acid, gallic acid, chlorogenic acid,
cinnamic acid, hydroxy protocatechuic acid, hydroxy benzoic
acid, caffeic acid, ferulic acid, coumaric acid, p-coumaric acid,
and o-coumaric acid, pelletierine, isopelletierine, methylpelle-
tierine, pseudopelletierine, punicalagin, punicalin, phloridzin,
quercetin, and catchin.6,7 Furthermore, the flavonoids of
Punica granatum L are luteolin, kaempferol, and narigenin
found in glycoside forms.7,8 The color of pomegranate is
induced by its compounds, specially anthocyanin. Anthocyanin
is a glycoside releasing a glucose molecule and a glycone ring
(anthocyanidin).9 Six anthocyanins are responsible for red
color of edible parts of Punica granatum L derived from pelar-
gonidin (orange and red colors), cyanidins (red and deep red
colors), and delphinidins (blue and purple colors); these are
3,5-diglucoside delphinidin, 3-glycoside delphinidin, 3,5-
diglucoside cyanidin, 3-glycoside cyanidin, 3,5-diglucoside
pelargonidin, and 3-glycoside pelargonidin.9,10
As long as Punica granatum L is matured, the color of the
fruit is gradually changed; however, this transformation in
color is very slow and increases after the middle stage of
maturation. In the earlier stages of development, the amount
of diglucoside anthocyanins seem to be higher than the mono-
glucoside forms; however, the trend changes inversely at the
end of the development and ripening stages.9
Also the proportion and type of the anthocyanins varies
depend on different cultivars.11 Antioxidant activity of pome-
granate fruit can be ascribed to the presence of some compo-
nents like ascorbic acid and phenolic compounds, including
punicalagin, punicalin, gallic acid, ellagic acid, and anthocya-
nins. These compounds are affected by fruit development as the
highest antioxidant activity was observed in newly formed
fruits (20 days).6,7 As the fruit grows, the antioxidant activity
reduces due to the decline in the level of ascorbic and phenolic
acids.12 Besides, antioxidant activity affected by phenolic com-
pounds and ascorbic acid varies among different varieties of
pomegranate plant (Sarkhosh A, Zamani Z, Fatahi R, unpub-
lished data). The oil derived from pomegranate seeds has
recently received more attention to be used in industrial process
and also in providing necessary fatty acids.13 Saturated and
unsaturated fatty acids account for the main proportions of fatty
acids composites. The ratios of fatty acids vary between 63 and
272 g/ kg dry weight of seed among different varieties.13 In the
most studied cultivars of pomegranate the predominant fatty
acids are linolenic (74% to 88%) and linoleic acid (5% to
16%).14 Furthermore, some fatty acids, including oleic acid,
palmitic acid, stearic acid, palmitoleic acid, arachidonic acid,
lauric acid, and caprylic acid are identified in different varieties
of Punica granatum L. Studies have shown that unsaturated
fatty acids are major components of lipids in sweet cultivars
of pomegranate fruit.13 Pomegranate seeds oil include steroidal
estrogens (g-tocopherol, 17-a-estradiol, stigmasterol, b-estriol
sitosterol, and testosterone) nonsteroidal compounds (compes-
trol, coumestrol).15
Application of Pomegranate in Traditional
Medicine
Flowers, leaves, bark of young shoots and roots, fruit peel, and
pomegranate sauce have been traditionally used.16 All compo-
nents of Punica granatum L fruit with abundant tannins show
relatively strong astringent effects. Several infusions or decoc-
tions of the plant flowers have been used in traditional medi-
cine to treat simple diarrhea, vaginal discharge, and also this
extract accompanied with pomegranate peel have usually been
gurgled to relieve pancreas inflammation of the pacreas.17
Refreshing juice of Punica granatum L fruit is recommended
to heal gallbladder diseases. The fruit contains strong tannin
considered as bitter nutrition. Its decoction appears to be help-
ful for treating diseases such as ordinary diarrhea, dysentery,
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and stomach disorders.17 Tannin content of pomegranate seed,
however, is not remarkable and it is usually used to treat
women vaginal discharge and wound healing.18 Fresh or dried
root barks or ethanol extracts of pomegranate are used to
remove intestinal parasites due to the alkaloid substances. It
is also used in traditional medicine because of the antibacterial
and anti-inflammatory properties.17,18
Pharmacological Properties of Pomegranate
Fermented juice of pomegranate fruit has been found to have
antioxidant activity. Extracted juice of pomegranate flowers
can reduce blood sugar and lipids.19 Flavonoids and tannins
of pomegranate juice can prevent the growth of cancer cells.20
Flavonoids observed in the watery extract and fruit peel have
shown estrogenic activity.21 In addition, luteolin and narin-
genin have indicated an activity similar to the hormone usually
secreted prior to pregnancy in women. Polyphenols of fermen-
ted extract of pomegranate fruit potentially appear to have anti-
oxidant activity and pericarp tannins may increases antioxidant
potential of fruit extract.22 The stronger activities in polyphe-
nols of fermented extract than nonfermented extract is likely
due to the breakdown of flavonoids sugar complexes during
fermentation that the final products will contain high concen-
trations of free polyphenols (with high biological activity).20
It has been proven that flavonoids contained in peels are found
in glycoside forms.20 They have no estrogenic activity in gly-
coside forms while they behave inversely when they are
released and hydrolyzed.23 The estrogenic effect of pericarp
polyphenols and pomegranate fermented juice is possibly
referred to their binding to the estrogen receptors like estro-
genic flavonoids, including kaempferol, quercetin, naringenin,
luteolin, caumestrol, and weak 17-a-estradiol estrogen so that it
prohibits estrogenic activity of 17-b-estradiol. Watery parts of
pomegranate can inhibit estrogen-dependent and estrogen-
independent breast cancer cells. However, this inhibitory effect
has been reported to be doubled for estrogen-dependent
case.23,24 Ellagic acid and gallic acid are among the constitu-
ents observed in pomegranate peels, and the former is a dimeric
derivative of gallic acid and is found mostly in higher plants,
such as fruits and nuts.25 Ellagic acid shows antimutant, anti-
viral, antioxidant, and skin-bleaching activity and has already
been added to food as an antioxidant in Japan.26 Antioxidant
capacity of extracts derived from pomegranate peel in produc-
ing phospholipid complex has been measured. The base of
method is established on the recovery of molybdenum(VI) to
molybdenum(V) using antioxidant compounds and creation
of green molybdenum(V) compounds with maximum absorp-
tion at 695 nm.27 Antioxidant capacity of extracts from pome-
granate peels is due to the presence of the phenols such as
ellagic tannins, ellagic acid, and gallic acid.20,28 Antimutagenic
and anticarcinogenic properties of the extracts were examined
against the azide sodium by the Ames test. The experiment
showed that juice extract of pomegranate peel can inhibit muta-
tion and cancer using azide sodium in 2 species of salmo-
nella.29 The results of the experiment showed that juice has
the lowest antioxidant activity and the highest antimutagenic
activity while methanol extract acts in the opposite way.
These abilities can be ascribed to the presence of phenols
and also their capacities in regulating the free radicals.29-32 The
seeds and thin whitish membrane in pomegranate constitutes
13% of the fruit. These 2 parts play a key role in diagnosis of
the disease, health of edible part of the fruit, especially in the
prevention of the fruit discoloration and browning. Such tissues
should be an enriched resource of active biological substances.
More recent studies have shown that the aforementioned parts
of the pomegranate fruit are enriched with a strong antioxidant
called punicalagin that controls superoxide and free radicals of
DPPH (1,1-diphenyl-2-picrylhydrazyl).22,33 The best extrac-
tion and separation way is done by methanol. Punicalagin is
capable to regulate the activity of superoxide and DPPH radi-
cals.34 Moreover, it can inhibit lipid peroxidation due to the
presence of hydroxyl groups in their structures and peroxida-
tion of the chain termination (by removing peroxide radi-
cals).24,34 The antioxidant activity of different parts of fruit
(peel, flesh, and seed) has been examined. This approach is
based on the reduction of a colored form of trivalent iron com-
pound called ferric-tripyridyltriazin in the presence of divalent
iron antioxidants. This method is known as FRAP (ferric reduc-
ing antioxidant power assay). In accordance with this method,
FRAP value of peel, flesh, and seed were 82.11, 3.1, and 0.72,
respectively.34
In an additional research, the blood plasma derived from
person who had taken pomegranate juice containing ellagic
acid (25 mg) and ellagitannins (318 mg, especially punicala-
gin) was analyzed.35 The main purpose of the earlier study was
to assess the amount and time duration of ellagic acid bioavail-
ability in plasma following consumption. According to the
results, the highest ratio of ellagic acid in the blood plasma was
measured at 0.5, 1, 2, 3, 4, 5, and 6 hours after taking pomegra-
nate juice. The highest and lowest ratios were observed at 1
hour and 4, 5, and 6 hours after consumption, respectively.
The presence of the free ellagic acid in the blood plasma is
induced by its breakdown under biologic pH of stomach. Thus,
it can be used as a biologic marker in bioavailability studies
confirming the consumption of ellagic acid from food
resources.25
Polyphenols of oil prohibit the activity of eicosanoid and
cyclooxygenase enzymes. 18C trans fatty acids known as con-
jugated linoleic acid, structurally related to punicic acid, pos-
sess cancer arresting properties.13
Protective chemical effects of pomegranate seed oil were
investigated for possible skin cancer development. Skin cancer
is among the most prevalent types of cancer in the United
States. About 1 000 000 cases of skin cancer and consequently
9000 deaths were reported in 2002.36 Increased incidence of
this type of cancer is mainly due to the permanent exposure
of skin to the environmental cancer-causing agents, especially
chemicals and ultraviolet radiation.36 The previous experi-
ments in order to prevention from skin cancer have proven the
functionality and application of natural products extracted from
onion and garlic oil. Skin cancer induced by chemicals and
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ultraviolet ray include 3 steps: (1) initiation, (2) increment, and
(3) promotion. Initiation step can be stimulated by application
of a skin carcinogen, that is, 7,12-dimethyl benzanthracene
(DMBA) in vivo (this reaction is necessarily irreversible);
however, it is noteworthy that applying such a substance for
one time cannot produce considerable tumors and it is only pos-
sible through permanent application of a tumor-promoting
agents like 12-O-tetradecanoylphyl phorbol 13-acetate (TPA).
Such tumor-promoting can provoke an enzyme known as
ornithinedecarboxylase (ODC) with a limited activity scope
in polyamine synthesis and also an important molecular agent
to chemical prevention from skin cancer.36 Pomegranate seed
oil consists of 80% conjugated fatty acids, particularly punic
acid and octadecatri enoic acid.13,37 Punic acid acts as an inhi-
bitor of prostaglandin biosynthesis as well as a cytotoxin for
cancer w2a cells; such activity is possibly due to the inhibitory
effect against fat peroxidation. Punic acid of pomegranate seed
oil inhibits prostaglandin biosynthesis (promote ornithine dec-
arboxylase enzyme activity at lower concentration).23 Also this
oil can prevent DMBA- and TPA-induced skin cancer.37,38
Inhibitory activities of prostaglandin as well as antioxidant
activity of polyphenols extracted from both pomegranate seed
oil and its fermented extract have widely been reported for pre-
vention from human breast cancer.36,39 Inhibitory impact of the
watery and oily parts of the fruit has been reported on breast can-
cer cells in vivo. Such parts prohibit the activity of enzymes
responsible for active estrogen biosynthesis (17-b-estradiol).
Since the watery and oily parts of the fruit are chemically differ-
ent, they probably act via different mechanisms in the prevention
of cancer.34,38,39 Pomegranate seed oil is considered as biosynth-
esis inhibitor E2 (17-b-estradiol) catalyzed by 17-b-hydroxys-
teroid enzyme. It also prevents invasion of cancer cells and
also can strengthen and encourage apoptosis.13 Extracted poly-
phenols of pomegranate seed oil can potentially prevent
cyclooxygenase activity; however, these activities were not
observed in the polyphenols of fermented extract.20,40 Inactiva-
tion of the mentioned enzyme prevents the proliferation of breast
cancer cells, its severity, and also the transformation of mam-
mals’ alveoli tissue (milk-producing units) to cancer mode.40
Clinical Applications of Pomegranate
Pomegranates are biologically unique and potent source of
many of the body’s physiological factors having significant
effects on human health.41 Pomegranate fruit has been recom-
mended as a pharmaceutical and food ingredient in treatment of
acquired immune deficiency syndrome (HIV/AIDS) due to the
enrichment of divers bioflavonoids, inhibition of free radicals,
as well as lipooxygenases inhibition (the enzymes that trans-
form arachidonic acid to leukotrienes).41
The pomegranate peels have traditionally used to treat ordi-
nary diarrhea and dysentery. The focus of future studies is con-
centrated on producing natural antidiarrhea remedy from
pomegranate peel for over-the-counter or prescription-based
medications.42 Pomegranate is identified as an antiparasitic
fruit for both humans and livestock.42 Flavonoids contained
in the fruit not only have powerful antioxidant activity but they
also have inhibitory effects on enzymes since the juice and oil
behave as potential nutritional supplement in enhancing long-
evity as well as preventing from heart disease and cancer.37
The extracted oil of pomegranate can effectively prohibit
the production of prostaglandin or leukotriene through inhibi-
tion of cycloxygenase and lipoxygenase eicosanoid enzymes
so that it may increase the application of oil or its derivatives
as internal or external anti-inflammatory substances.37
The recent focus on the use of phytoestrogenic compounds
in medicine for the prevention and treatment of menopause,
osteoporosis, and cardiovascular diseases induced by reduced
estrogen and cancer may possibly increase the prospect of
using pomegranate seed oil and juice for postmenopausal
women to be replaced by internal and external phytoestrogen
as an alternative to hormone replacement therapy (HRT).
Discussion
Pomegranate possesses a wide range of compounds, including
polyphenols, alkaloids, and vitamins with potent free radical
scavenging properties.43 Free radicals can cause oxidative
stress, which may induce damage to biomolecules, leading to
many chronic diseases, such as cancer,44,45 diabetes,46,47 ather-
osclerosis,48,49 Alzheimer’s disease,50,51 nephrotoxicity,52,53
hepatotoxicity,54,55 pain,56,57 and other degenerative diseases.
Antioxidant activity of pomegranate fruit has been attributed
to the presence of some components like ascorbic acid and phe-
nolic compounds, including punicalagin, punicalin, gallic acid,
ellagic acid, and anthocyanins.2 Pomegranate tannins, espe-
cially ellagitannins are also the most abundant polyphenols that
have shown potent free radical scavenging properties. Punica-
lagins and ellagitannins are converted to urolithins by bacteria
in the intestine, and these to have antioxidant activity.37 The
red color of pomegranate juice has been attributed to anthocya-
nins, such as cyanidin, pelargonidin glycosides, and delphini-
din, which have potent antioxidant activity.37
Preclinical and clinical researches have revealed that plants
antioxidants are effective in prevention and treatment of free
radical–induced complications such as low-density lipoprotein
oxidation,58,59 heart disease,60,61 diabetes,62,63 cancer,64,65 cog-
nition problem,66,67 and infectious diseases.68-70 Therefore, the
medicinal properties of pomegranate, at least in part, can be
attributed to its components with antioxidant activities. If it
is true, other medicinal plants with antioxidant activity71-89
might have the same properties.
These compounds with antioxidant activity are affected by
fruit development. The highest antioxidant activity has been
observed in newly formed fruits (20 days).6,7 As the fruit
grows, the antioxidant activity reduces because of the decline
in the level of ascorbic and phenolic acids.12 Besides, the anti-
oxidant activity varies among different varieties of pomegra-
nate plant (Sarkhosh A, Zamani Z, Fatahi R, unpublished
data). Therefore, different varieties of pomegranate may not
have the same medicinal property and they are better consumed
fresh, while in the early stages of development.
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Other components of pomegranate should be analyzed and
evaluated to realize their role in the treatment of diseases.
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